Tongling Group: Controlling shareholders are planning to change from Shangkun Biotech to Shangkun Consultation.

date
16/09/2025
Tongling Corporation announced on September 15, 2025, Shangkun Biotechnology and Shangkun Consulting signed a "Share Transfer Agreement". According to the agreement, Shangkun Biotechnology will transfer all of its 29.08% stake in the company to Shangkun Consulting. Shangkun Biotechnology will no longer hold any shares in the company, and the controlling shareholder will change from Shangkun Biotechnology to Shangkun Consulting.